Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Sitemap: |
Title | High LDL-C Injection Treatment | Repatha® |
Description | Learn how Repatha® (evolocumab), a PCSK9 inhibitor, can reduce risk of stroke and myocardial infarction in your patients with established |
Keywords | N/A |
WebSite | repathahcp.com |
Host IP | 54.148.237.9 |
Location | United States |
Site | Rank |
US$23,034,442
Last updated: 2023-04-29 02:26:38
repathahcp.com has Semrush global rank of 459,499. repathahcp.com has an estimated worth of US$ 23,034,442, based on its estimated Ads revenue. repathahcp.com receives approximately 2,657,821 unique visitors each day. Its web server is located in United States, with IP address 54.148.237.9. According to SiteAdvisor, repathahcp.com is safe to visit. |
Purchase/Sale Value | US$23,034,442 |
Daily Ads Revenue | US$21,263 |
Monthly Ads Revenue | US$637,877 |
Yearly Ads Revenue | US$7,654,523 |
Daily Unique Visitors | 177,189 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
repathahcp.com. | A | 300 | IP: 54.148.237.9 |
repathahcp.com. | A | 300 | IP: 54.201.250.38 |
repathahcp.com. | NS | 86400 | NS Record: ns-765.awsdns-31.net. |
repathahcp.com. | NS | 86400 | NS Record: ns-1123.awsdns-12.org. |
repathahcp.com. | NS | 86400 | NS Record: ns-184.awsdns-23.com. |
repathahcp.com. | NS | 86400 | NS Record: ns-2027.awsdns-61.co.uk. |
repathahcp.com. | MX | 300 | MX Record: 3 amgen-com.mail.protection.outlook.com. |
repathahcp.com. | TXT | 300 | TXT Record: facebook-domain-verification=ljqsix508mak14g49tek4i1qporjc8 |
Indications Repatha ® is indicated: In adults with established cardiovascular disease to reduce the risk of myocardial infarction, stroke, and coronary revascularization As an adjunct to diet, alone or in combination with other low-density lipoprotein cholesterol (LDL-C)-lowering therapies, in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH) to reduce LDL-C Indications Important Safety Information Prescribing Information Medical Information For Patients Prescribing Information Instructions for Use—SureClick® Instructions for Use—Pushtronex® Patient Product Information Home About Repatha ® Dosing Mechanism of Action Why Add Repatha<sup>®</sup>? The Role of Statin Therapy More Can Be Done The Right Repatha® Patients Statins + Repatha® PCSK9i mAbs in ASCVD Efficacy FOURIER Clinical Trial Safety Patient & Practice Resources Virtual Resources Coverage Information Repatha® Copay Card |
HTTP/1.1 403 Forbidden Server: awselb/2.0 Date: Thu, 21 Oct 2021 23:46:48 GMT Content-Type: text/html Content-Length: 118 Connection: keep-alive |
Domain Name: REPATHAHCP.COM Registry Domain ID: 1900849401_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2018-07-25T20:50:04Z Creation Date: 2015-02-04T23:53:37Z Registry Expiry Date: 2023-02-04T23:53:37Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1123.AWSDNS-12.ORG Name Server: NS-184.AWSDNS-23.COM Name Server: NS-2027.AWSDNS-61.CO.UK Name Server: NS-765.AWSDNS-31.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T18:32:12Z <<< |